Menu
Back to User profile » Dr Ubaldo Martin
Papers published by Dr Ubaldo Martin:
Targeting TSLP in Asthma
Parnes JR, Molfino NA, Colice G, Martin U, Corren J, Menzies-Gow A
Journal of Asthma and Allergy 2022, 15:749-765
Published Date: 3 June 2022
Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum]
Panettieri RA Jr, Welte T, Shenoy KV, Korn S, Jandl M, Kerwin EM, Feijoo R, Barker P, Olsson RF, Martin UJ
Journal of Asthma and Allergy 2020, 13:135-136
Published Date: 13 March 2020
Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA)
Panettieri RA Jr, Welte T, Shenoy KV, Korn S, Jandl M, Kerwin EM, Feijoo R, Barker P, Olsson RF, Martin UJ
Journal of Asthma and Allergy 2020, 13:115-126
Published Date: 17 February 2020
Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies
Martinez FJ, Rabe KF, Lipworth BJ, Arora S, Jenkins M, Martin UJ, Reisner C
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:99-106
Published Date: 9 January 2020
Efficacy And Safety Of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Formulated Using Co-Suspension Delivery Technology In Chinese Patients With COPD
Chen R, Zhong N, Wang HY, Zhao L, Mei X, Qin Z, Huang J, Assam PN, Maes A, Siddiqui S, Martin UJ, Reisner C
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:43-56
Published Date: 8 January 2020
Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe Asthma
FitzGerald JM, Bleecker ER, Bourdin A, Busse WW, Ferguson GT, Brooks L, Barker P, Martin UJ
Journal of Asthma and Allergy 2019, 12:401-413
Published Date: 9 December 2019
Single-Use Autoinjector Functionality And Reliability For At-Home Administration Of Benralizumab For Patients With Severe Asthma: GRECO Trial Results
Ferguson GT, Cole J, Aurivillius M, Roussel P, Barker P, Martin UJ
Journal of Asthma and Allergy 2019, 12:363-373
Published Date: 23 October 2019
Sputum Streptococcus pneumoniae is reduced in COPD following treatment with benralizumab
George L, Wright A, Mistry V, Sutcliffe A, Chachi L, Haldar K, Ramsheh MY, Richardson M, van der Merwe R, Martin U, Newbold P, Brightling CE
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:1177-1185
Published Date: 5 June 2019
Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USA
Lipworth BJ, Collier DJ, Gon Y, Zhong NS, Nishi K, Chen R, Arora S, Maes A, Siddiqui S, Reisner C, Martin UJ
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2969-2984
Published Date: 26 September 2018
A randomized study using functional respiratory imaging to characterize bronchodilator effects of glycopyrrolate/formoterol fumarate delivered by a metered dose inhaler using co-suspension delivery technology in patients with COPD
De Backer W, De Backer J, Vos W, Verlinden I, Van Holsbeke C, Clukers J, Hajian B, Siddiqui S, Jenkins M, Reisner C, Martin UJ
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2673-2684
Published Date: 30 August 2018
Pharmacokinetics of glycopyrronium/formoterol fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD
Ferguson GT, Rodriguez-Roisin R, Reisner C, Maes A, Siddiqui S, Martin UJ
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:945-953
Published Date: 21 March 2018